Home » Topics » Regulatory » Patents

Patents
RSS

Mirati Therapeutics and Array BioPharma describe new mutant KRAS inhibitors

Dec. 5, 2017

ViiV Healthcare UK patents novel HIV integrase inhibitors

Dec. 5, 2017

Stanford University describes novel adrenergic receptor modulators

Dec. 5, 2017

Istituto Europeo di Oncologia describes novel KDM4C inhibitors

Dec. 4, 2017

Enanta Pharmaceuticals presents novel farnesoid X receptor agonists

Dec. 4, 2017

Prolyl endopeptidase inhibitors identified at Bayer

Dec. 4, 2017

New proteolysis targeting chimera compounds presented by C4 Therapeutics

Dec. 4, 2017

Femtogenix synthesizes novel anticancer conjugate compounds

Dec. 4, 2017

Enanta patents novel farnesoid X receptor agonists

Dec. 1, 2017

Novel AMP-activated protein kinase activators generated at Shionogi

Dec. 1, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...